Evidence map›Paper›PMID 35687418›Full record

ArticleJMIR research protocols2022

The First National Remote Emergency System for Malignant Hyperthermia (MH-NRES) in China: Protocol for the Design, Development, and Evaluation of a WeChat Applet.

Hong Yu, Lingcan Tan, Yi Teng, Zhao Xu, Kun Xiao, Jin Yin, Yunxia Zuo, Tao Zhu, Xiaoqian Deng

Abstract read
In one paragraph

Article in JMIR research protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hong YuDepartment of Anesthesiology, Sichuan University West China Hospital, Chengdu, China.ORCID https://orcid.org/0000-0003-0084-3318
Lingcan TanDepartment of Anesthesiology, Sichuan University West China Hospital, Chengdu, China.ORCID https://orcid.org/0000-0002-8798-9063
Yi TengDepartment of Anesthesiology, Sichuan University West China Hospital, Chengdu, China.ORCID https://orcid.org/0000-0002-3367-3020
Zhao XuDepartment of Anesthesiology, Sichuan University West China Hospital, Chengdu, China.ORCID https://orcid.org/0000-0001-5831-4975
Kun XiaoSchool of Information and Software Engineering, University of Electronic Science and Technology of China, Chengdu, China.ORCID https://orcid.org/0000-0001-6588-0457
Jin YinWest China Biomedical Big Data Center, Sichuan University West China Hospital, Chengdu, China.ORCID https://orcid.org/0000-0002-8607-091X
Yunxia ZuoDepartment of Anesthesiology, Sichuan University West China Hospital, Chengdu, China.ORCID https://orcid.org/0000-0002-3539-5706
Tao ZhuDepartment of Anesthesiology, Sichuan University West China Hospital, Chengdu, China.ORCID https://orcid.org/0000-0001-9196-1736
Xiaoqian DengDepartment of Anesthesiology, Sichuan University West China Hospital, Chengdu, China.ORCID https://orcid.org/0000-0001-6694-8513

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalignant hyperthermia (MH) is a rare life-threatening anesthetic emergency. With respect to the high fatality rate, difficulty in early recognition, and the lack of disease-specific drug (ie, dantrolene) in China, more effort is needed to strengthen early diagnosis and effective treatment of MH emergencies. Nowadays, mobile health (mHealth) apps are changing the way of medical practice; they can serve as an accessible tool to help anesthesiologists deal with MH crises. However, no related mHealth-based emergency system is available currently.

objectiveThe aim of this study is to outline the protocol for the development of a WeChat applet used to design a National Remote Emergency System for Malignant Hyperthermia (MH-NRES) in China, as well as the protocol for the evaluation of the user experience and perception of the system.

methodsThe system adopts the client-server architecture, with a custom user interface operating as clients and the back-end system operating as the server. The client-side software was developed using uni-app technology with Vue.js-based framework, which consists of 6 modules: Quick Diagnosis, Dantrolene Mobilization, Instruction on Dantrolene Use, MH Treatment, Recovery Period Treatment, and DNA Test and Biopsy. The back-end system was developed based on the Spring framework. The system will be evaluated by administrating a modified user version of the Mobile App Rating Scale. Pilot testing will be conducted in Sichuan Province, China, and a subsequent evaluation on a national scale is planned.

resultsThe theoretical framework design of this system was completed in August 2021. The development of the system was completed in February 2022, and the refinement is currently ongoing. Pilot testing after the implementation of the system in Sichuan Province is planned to take 2 months, and the subsequent evaluation on a national scale is planned to take 2 months.

conclusionsWe have described a novel approach using the WeChat applet to develop the MH-NRES. Findings from the usability testing process in the current study may lead to refinements and is expected to suggest that this system is both feasible and welcomed by anesthesiologists. Depending on the availability of research funding, this system will be extended nationally across China. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/37084.

Indexed as

anesthesiaanesthesiologistanesthesiologyanestheticappletcalling appChinaChinesedantrolenedevelopmentdiagnosisdiagnostic servicedigital healthemergencyevaluationhealth apphyperthermiamalignant hyperthermiamessaging appmHealthmobile healthnational remote emergency systemperceptionuni-appuser experienceWeChatWeChat applet

Identifiers

PMID35687418
PMCPMC9233253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.